The newly published paper by Gunnveig Grodeland et al: DNA Vaccine that Targets Hemagglutinin to MHC Class II Molecules Rapidly Induces Antibody-Mediated Protection against Influenza, describes the vaccibody platform as a robust and effective vaccine for prophylactic use. The paper can be downloaded here
